Latest Period
Q1 2026
Security Snapshot
CorMedix Inc. - Common stock, $0.001 par value (CRMD) Institutional Ownership
CUSIP: 21900C308
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
179
Shares (Excl. Options)
40,253,132
Price
$6.79
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common stock, $0.001 par value
- Symbol
- CRMD on Nasdaq
- Shares outstanding
- 79,018,589
- Price per share
- $7.49
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 40,253,132
- Total reported value
- $273,289,314
- % of total 13F portfolios
- 0%
- Share change
- -1,135,856
- Value change
- -$30,360,505
- Number of holders
- 179
- Price from insider filings
- $7.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CRMD - CorMedix Inc. - Common stock, $0.001 par value is tracked under CUSIP 21900C308.
- 179 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 200 to 179 between Q4 2025 and Q1 2026.
- Reported value moved from $487,974,048 to $273,289,314.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 179 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 21900C308?
CUSIP 21900C308 identifies CRMD - CorMedix Inc. - Common stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 21900C308:
Significant Owners of CorMedix Inc. - Common stock, $0.001 par value (CRMD) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | +28% | $44,985,125 | +$9,454,283 | 6,274,076 | +27% | Deep Track Capital, LP | 31 Mar 2026 |
| SHAIBATALHAMD AYMEN ABDALKADER | 5.8% | -6.7% | $44,390,000 | -$440,330 | 4,600,000 | -0.98% | SHAIBATALHAMD AYMEN ABDALKADER | 01 Jan 2026 |
| BlackRock, Inc. | 7.5% | $41,659,221 | 4,567,897 | BlackRock, Inc. | 31 Dec 2024 |
As of 31 Mar 2026, 179 institutional investors reported holding 40,253,132 shares of CorMedix Inc. - Common stock, $0.001 par value (CRMD). This represents 51% of the company’s total 79,018,589 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | 6,274,076 | +19% | 0.88% | $42,600,976 |
| BlackRock, Inc. | 7.6% | 5,967,575 | +3.3% | 0% | $40,519,834 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 3,129,656 | 0% | 0% | $21,250,364 |
| STATE STREET CORP | 2.8% | 2,191,843 | +14% | 0% | $14,882,614 |
| ROYCE & ASSOCIATES LP | 2.4% | 1,887,532 | +680% | 0.13% | $12,816,342 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,816,907 | -5% | 0% | $12,339,852 |
| UBS Group AG | 1.9% | 1,538,245 | +142% | 0% | $10,444,683 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.5% | 1,211,115 | +50% | 0.24% | $8,223,471 |
| Alyeska Investment Group, L.P. | 1.1% | 850,000 | 0% | 0.02% | $5,771,500 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.94% | 742,571 | 0% | 0% | $5,042,057 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.85% | 673,302 | +2.3% | 0.1% | $4,571,721 |
| NORTHERN TRUST CORP | 0.81% | 637,683 | +3.8% | 0% | $4,329,868 |
| Palisades Investment Partners, LLC | 0.77% | 610,148 | +5.8% | 1.6% | $4,143,007 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.76% | 602,966 | -1.3% | 0% | $4,094,139 |
| Trexquant Investment LP | 0.71% | 560,637 | 0.03% | $3,806,725 | |
| GOLDMAN SACHS GROUP INC | 0.65% | 511,329 | -38% | 0% | $3,471,924 |
| VANGUARD FIDUCIARY TRUST CO | 0.64% | 505,679 | 0% | 0% | $3,433,560 |
| Private Advisor Group, LLC | 0.64% | 504,668 | +33% | 0.02% | $3,426,716 |
| MARSHALL WACE, LLP | 0.64% | 502,965 | -74% | 0% | $3,415,131 |
| VICTORY CAPITAL MANAGEMENT INC | 0.63% | 499,803 | +59% | 0% | $3,393,662 |
| MORGAN STANLEY | 0.55% | 435,639 | -33% | 0% | $2,957,992 |
| Bank of New York Mellon Corp | 0.46% | 366,513 | -2.8% | 0% | $2,488,626 |
| Sculptor Capital LP | 0.43% | 335,900 | 0.03% | $2,280,761 | |
| RAYMOND JAMES FINANCIAL INC | 0.42% | 328,224 | -29% | 0% | $2,228,641 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.38% | 297,463 | -7.3% | 0% | $2,019,774 |
Institutional Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 40,253,132 | $273,289,314 | -$30,360,505 | $6.79 | 179 |
| 2025 Q4 | 41,963,960 | $487,974,048 | -$15,316,010 | $11.63 | 200 |
| 2025 Q3 | 43,121,910 | $501,528,237 | +$101,799,375 | $11.63 | 189 |
| 2025 Q2 | 34,151,234 | $420,699,898 | +$142,837,808 | $12.32 | 169 |
| 2025 Q1 | 23,724,937 | $146,235,596 | +$397,499 | $6.16 | 135 |
| 2024 Q4 | 22,893,836 | $185,441,545 | +$29,955,443 | $8.10 | 126 |
| 2024 Q3 | 19,135,638 | $154,655,147 | +$21,831,393 | $8.08 | 100 |
| 2024 Q2 | 17,129,390 | $74,162,669 | -$748,246 | $4.33 | 97 |
| 2024 Q1 | 17,269,642 | $73,216,929 | -$5,693,027 | $4.24 | 89 |
| 2023 Q4 | 18,742,007 | $70,461,032 | +$3,045,526 | $3.76 | 101 |
| 2023 Q3 | 17,891,223 | $66,197,207 | -$5,485,628 | $3.70 | 92 |
| 2023 Q2 | 19,187,043 | $76,065,204 | +$33,053,416 | $3.96 | 86 |
| 2023 Q1 | 10,770,110 | $44,582,136 | -$1,863,278 | $4.14 | 64 |
| 2022 Q4 | 11,182,776 | $47,050,210 | +$1,816,100 | $4.22 | 62 |
| 2022 Q3 | 10,928,271 | $31,131,890 | -$4,497,215 | $2.83 | 66 |
| 2022 Q2 | 12,425,504 | $49,348,797 | -$5,601,808 | $4.02 | 69 |
| 2022 Q1 | 13,362,668 | $73,354,516 | +$1,886,576 | $5.48 | 83 |
| 2021 Q4 | 13,046,114 | $59,435,463 | +$5,549,733 | $4.55 | 78 |
| 2021 Q3 | 11,793,247 | $54,910,109 | +$1,590,384 | $4.65 | 75 |
| 2021 Q2 | 11,351,356 | $77,873,368 | +$3,221,689 | $6.86 | 77 |
| 2021 Q1 | 10,781,064 | $107,630,096 | +$16,345,897 | $9.99 | 76 |
| 2020 Q4 | 9,261,298 | $68,791,909 | +$7,239,796 | $7.43 | 74 |
| 2020 Q3 | 8,327,514 | $50,205,664 | +$9,581,252 | $6.03 | 70 |
| 2020 Q2 | 6,739,459 | $42,456,689 | +$1,328,313 | $6.30 | 67 |
| 2020 Q1 | 6,612,416 | $23,732,293 | -$6,155,816 | $3.59 | 57 |
| 2019 Q4 | 6,440,146 | $46,873,565 | +$176,523 | $7.28 | 62 |
| 2019 Q3 | 6,472,987 | $41,291,108 | +$6,489,686 | $6.38 | 55 |
| 2019 Q2 | 5,421,031 | $48,610,180 | +$15,505,635 | $8.97 | 45 |
| 2019 Q1 | 3,663,429 | $34,616,000 | +$34,616,000 | $9.45 | 37 |